<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Gynecologic Oncology News</title> 
<link>http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/399</link> 
<description>Gynecologic Oncology</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2981376</link> 
<pubDate>12/20/2009</pubDate> 
<description><![CDATA[<b>BMC Cancer</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2981376</guid>
</item> 
 

<item> 
<title><![CDATA[Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985669</link> 
<pubDate>12/20/2009</pubDate> 
<description><![CDATA[<b>Cancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985669</guid>
</item> 


 

<item> 
<title><![CDATA[Adult-Type Granulosa Cell Tumors and FOXL2 Mutation]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985664</link> 
<pubDate>12/20/2009</pubDate> 
<description><![CDATA[<b>Cancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2985664</guid>
</item> 
 
 


  


</channel> 
</rss>

